title: Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
abstract: The antimicrobial susceptibility profile of 419 clinical isolates of Pseudomonas aeruginosa obtained from intensive care unit patients was determined. Amikacin and piperacillin/tazobactam were the most active antimicrobials evaluated. Fifty isolates (11.9%) were resistant to antimicrobials from > or =3 classes. Ninety-six percent of multidrug-resistant (MDR) isolates remained fully susceptible to colistin (polymyxin E).
authors.affiliation: Department of Medicine, Health Sciences Centre, Winnipeg, MB, Canada. awalkty@mts.net
authors.forename: Andrew
authors.initials: A
authors.lastname: Walkty
authors.forename: Melanie
authors.initials: M
authors.lastname: Decorby
authors.forename: Kim
authors.initials: K
authors.lastname: Nichol
authors.forename: Michael R
authors.initials: MR
authors.lastname: Mulvey
authors.forename: Daryl
authors.initials: D
authors.lastname: Hoban
authors.forename: George
authors.initials: G
authors.lastname: Zhanel
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002170:Canada; D024881:Drug Resistance, Bacterial; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents